Dragonfly Therapeutics

This early-phase study tested a new drug called DF6215, alone or with another drug (pembrolizumab), in 35 adults with advanced solid tumors that could not be removed by surgery or had spread. The main goals were to find the safest dose and check for side effects. The study is com…

This early-phase study tested a new experimental drug called DF6002, given alone or with the immunotherapy nivolumab, in 170 people with advanced solid tumors that had stopped responding to standard treatments. The main goals were to check safety, find the right dose, and see if …

This study tested a new drug called DF9001 in 24 adults with advanced solid tumors that have not responded to other treatments. The drug works by helping the body's immune cells recognize and attack cancer cells. The main goals were to check safety and find the best dose, both wh…